Event
Neuralink launches CONVOY feasibility study for robotic arm control
Key points
- Neuralink received approval and launched CONVOY, a feasibility study extending N1 Implant control to an assistive robotic arm.
- CONVOY is designed to evaluate whether people with paralysis can use the N1 Implant to control external robotic assistance.
- The study expands Neuralink's device-control work from computer interfaces toward physical assistive machines.
Company context
Neuralink is a neurotechnology company developing implantable brain-computer interfaces for people with unmet medical needs, beginning with device control for people with paralysis. Its system combines the N1 Implant, external software, wireless communication, and the R1 surgical robot used to place ultra-fine electrode threads in the brain.
Context
- Company
- Neuralink
- Segment
- Healthcare
- Event type
- Regulatory
- Geography
- Fremont · United States